Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome

C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force

(2013) David I. Buckley et al.   ANNALS OF INTERNAL MEDICINE

Divergences in Insulin Resistance Between the Different Phenotypes of the Polycystic Ovary Syndrome

(2013) Paolo Moghetti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: Data from the Heart and Soul Study

(2012) Ruth Dubin et al.   AMERICAN HEART JOURNAL

Cardiometabolic Aspects of the Polycystic Ovary Syndrome

(2012) Harpal S. Randeva et al.   ENDOCRINE REVIEWS

High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome

(2012) Aydogan Aydogdu et al.   GYNECOLOGICAL ENDOCRINOLOGY

Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study

(2012) T. Piltonen et al.   HUMAN REPRODUCTION

Pentraxin 3: A novel and independent prognostic marker in ischemic stroke

(2011) Wi-Sun Ryu et al.   ATHEROSCLEROSIS

Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes

(2011) Carlo Pergola et al.   FASEB JOURNAL

Abnormal expression of growth differentiation factor 9 and bone morphogenetic protein 15 in stimulated oocytes during maturation from women with polycystic ovary syndrome

(2011) Li-Na Wei et al.   FERTILITY AND STERILITY

The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling

(2011) A. Inforzato et al.   TISSUE ANTIGENS

Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis

(2010) Héctor F. Escobar-Morreale et al.   FERTILITY AND STERILITY

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

(2010) Robert A. Wild et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Long Pentraxin PTX3: A Modulator of the Immunoinflammatory Response in Atherosclerosis and Cardiovascular Diseases

(2010) Giuseppe Danilo Norata et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Associations of Pentraxin 3 With Cardiovascular Disease and All-Cause Death

(2009) Nancy Swords Jenny et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations

(2009) Kazumi Yamasaki et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Testosterone Induces Redistribution of Forkhead Box-3a and Down-Regulation of Growth and Differentiation Factor 9 Messenger Ribonucleic Acid Expression at Early Stage of Mouse Folliculogenesis

(2009) Jun-Ling Yang et al.   ENDOCRINOLOGY

Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome

(2009) Flavia Tosi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary syndrome

(2009) Shu-Yun Zhao et al.   FERTILITY AND STERILITY

The soluble pattern recognition receptor pentraxin-3 in innate immunity, inflammation and fertility

(2009) Cecilia Garlanda et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)

(2008) Masato Yoneda et al.   BMC GASTROENTEROLOGY

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

(2008) Ricardo Azziz et al.   FERTILITY AND STERILITY